The findings may increase scrutiny about the usefulness of the treatment, molnupiravir, which was one of the first Covid drugs available to doctors worldwide during the pandemic. Molnupiravir works by ...

The FDA said Friday that Merck's anti-COVID-19 pill is effective in treating the virus but said that regulators will meet next week to investigate whether the pill is safe for people who are pregnant ...

Merck (MRK) and Ridgeback Biotherapeutics announced today that their COVID-19 pill — the first oral antiviral of its kind — cut the risk of hospitalizations or deaths by half, and that they would ...

WASHINGTON - Pfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed the pill's ...

Pharmaceutical giant Merck said it plans to acquire privately held OncoImmune for $425 million in cash, gaining rights to an under-the-radar drug that has shown striking results in hospitalized ...

Drugmaker Merck has officially asked the FDA to authorize its pill for COVID-19, saying it can reduce the risk of hospitalization. But, just how much of a gamechanger could it really be? READ MORE: ...

Sept 11 (Reuters) - U.S. drugmaker Merck & Co Inc (MRK.N), opens new tab has begun recruiting participants to its early-stage COVID-19 vaccine study, according to the government database ...

Stream Connecticut News for free, 24/7, wherever you are. The findings may increase scrutiny about the usefulness of the treatment, molnupiravir, which was one of the first Covid drugs available to ...